References
Guilford Pharmaceuticals Inc. Guilford Pharmaceuticals Announces DRL Files Marketing Application for DOPAS-CAN(R) Injection Filed in Japan. Media Release: 10 Jul 2003. Available from URL: http://www.guilfordpharm.com
Guilford Pharmaceuticals and Parkinson Study Group announce positive clinical results with DOPASCAN (Rm), Parkinson’s disease diagnostic agent. PR Newswire [online]: 9 Jun 1997. Available from URL: http://www.newspage.com
Gatley SJ, Volkow ND, Chen R. Displacement of RTI-55 from the dopamine transporter by cocaine. European Journal of Pharmacology 296: 145–151, 25 Jan 1996
Rights and permissions
About this article
Cite this article
Iometopane. Drugs R&D 4, 320–322 (2003). https://doi.org/10.2165/00126839-200304050-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200304050-00008